Benfa Gong

5PUBLICATIONS

12CO-AUTHORS

Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|May 27, 2026

Gene- and subtype-dependent prognostic impact of ras pathway mutations in acute myeloid leukemia: a cohort study of 2,500 patients.

|May 21, 2026

Venetoclax Plus Pediatric Regimen in Adolescents and Adults with Ph-Negative Acute Lymphoblastic Leukemia.

|Sep 05, 2025

Correction: Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trial.

Xiaoyuan Gong, Wenbing Liu, Yuntao Liu

|Jun 30, 2025

Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trial.

Xiaoyuan Gong, Wenbing Liu, Yuntao Liu

|Feb 13, 2024

Treatment Patterns and <i>FLT3</i> Mutation Testing Among Patients with Acute Myeloid Leukemia in China: A Retrospective Observational Study.

Benfa Gong, Li-Jen Cheng, Christopher H Young

Pageof 1

Frequent Collaborators

Jianxiang Wang

Xiaoyuan Gong

Kaiqi Liu

Shaowei Qiu

Hui Wei

Runxia Gu

Ying Wang

Yingchang Mi

Wenbing Liu

Ying Wang

Frequent Collaborators

Jianxiang Wang

Xiaoyuan Gong

Kaiqi Liu

Shaowei Qiu